Title : ERCC1 and topoisomerase I expression in small cell lung cancer: prognostic and predictive implications.

Pub. Date : 2012 Jun

PMID : 22344449






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Topotecan is the standard treatment as second-line therapy and it is an inhibitor of topoisomerase I (TOP I). Topotecan DNA topoisomerase I Homo sapiens